Skip to main content

CORRECTION article

Front. Pharmacol., 30 September 2021
Sec. Drugs Outcomes Research and Policies
Volume 12 - 2021 | https://doi.org/10.3389/fphar.2021.765748

Corrigendum: Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014–2018: Findings and Implications From ESAC-Net and WHO Europe

This article is a correction to:

  1. Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014–2018: Findings and Implications from ESAC-Net and WHO Europe

    1. Read original article
Jane Robertson,Jane Robertson1,2Vera Vlahovi&#x;-Pal evskiVera Vlahović-Palčevski3Kotoji Iwamoto Kotoji Iwamoto1*Liselotte Diaz HgbergLiselotte Diaz Högberg4Brian Godman,Brian Godman5,6Dominique L. MonnetDominique L. Monnet4Sarah GarnerSarah Garner1Klaus Weist ESAC-Net Study GroupKlaus Weist4 ESAC-Net Study GroupWHO Europe AMC Network Study Group WHO Europe AMC Network Study Group
  • 1World Health Organization Regional Office for Europe, Copenhagen, Denmark
  • 2Department of Clinical Pharmacology, The University of Newcastle, Callaghan, NSW, Australia
  • 3Department of Clinical Pharmacology, University Hospital Rijeka/Medical Faculty and Faculty of Health Studies, University of Rijeka, Rijeka, Croatia
  • 4European Centre for Disease Prevention and Control, Solna, Sweden
  • 5Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom
  • 6Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa

A Corrigendum on
Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014–2018: Findings and Implications from ESAC-Net and WHO Europe

by Robertson, J., Vlahović-Palčevski, V., Iwamoto, K., Högberg, L. D., Godman, B., Monnet, D. L., Garner, S., Weist, K., ESAC-Net Study Group and WHO Europe AMC Network Study Group (2021). Front. Pharmacol. 12:639207. doi: 10.3389/fphar.2021.639207

In the Discussion, subsection Group Authors, a name was incorrectly spelled as Leva Rutkovska. The correct spelling is Ieva Rutkovska.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: antibiotic utilization, antimicrobial medicines consumption, AWaRe classification, cross-national comparative study, drug utilization 75%, European Surveillance of Antibiotic Consumption Network, Eastern Europe, Central Asia

Citation: Robertson J, Vlahović-Palčevski V, Iwamoto K, Högberg LD, Godman B, Monnet DL, Garner S and Weist K (2021) Corrigendum: Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014–2018: Findings and Implications From ESAC-Net and WHO Europe. Front. Pharmacol. 12:765748. doi: 10.3389/fphar.2021.765748

Received: 27 August 2021; Accepted: 09 September 2021;
Published: 30 September 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright ©World Health Organization 2021. Licensee Frontiers Media SA. This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (http://creativecommons.org/licenses/by/3.0/igo/legalcode), which permits unrestricted use, adaptation (including derivative works), distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction or adaptation of this article there should not be any suggestion that WHO or this article endorse any specific organisation or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.

*Correspondence: Kotoji Iwamoto, iwamotok@who.int

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.